These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8076444)

  • 21. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study.
    Jager A; Kostense PJ; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD
    Diabetologia; 1998 Jun; 41(6):694-700. PubMed ID: 9662052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM.
    Schmitz A; Vaeth M; Mogensen CE
    Diabetologia; 1994 Dec; 37(12):1251-8. PubMed ID: 7895955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
    BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.
    Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y
    Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
    Mayaudon H; Bauduceau B; Ducorps M; Belmejdoub G; Poirier JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.
    Islam N; Kazmi F; Chusney GD; Mattock MB; Zaini A; Pickup JC
    Diabetes Care; 1998 Mar; 21(3):385-8. PubMed ID: 9540020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study).
    Yang CW; Park JT; Kim YS; Kim YL; Lee YS; Oh YS; Kang SW
    Nephrol Dial Transplant; 2011 Oct; 26(10):3249-55. PubMed ID: 21372264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.
    Torffvit O; Agardh CD
    J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microalbuminuria and clinical correlates in black African patients with type 2 diabetes.
    Adetunji OR; Adeleye JO; Agada NO; Salako BL
    West Afr J Med; 2006; 25(4):279-83. PubMed ID: 17402516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus.
    Haneda M; Kikkawa R; Togawa M; Koya D; Kajiwara N; Uzu T; Shigeta Y
    J Diabetes Complications; 1992; 6(3):181-5. PubMed ID: 1472744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 10-year incidence of renal insufficiency in people with type 1 diabetes.
    Klein R; Klein BE; Moss SE; Cruickshanks KJ; Brazy PC
    Diabetes Care; 1999 May; 22(5):743-51. PubMed ID: 10332675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for the progression of microalbuminuria in Japanese type 2 diabetic patients--a 10 year follow-up study.
    Oue T; Namba M; Nakajima H; Ono A; Horikawa Y; Yamamoto K; Hamaguchi T; Fujino-Kurihara H; Yamasaki T; Tomita K; Miyagawa J; Hanafusa T; Matsuzawa Y
    Diabetes Res Clin Pract; 1999 Oct; 46(1):47-55. PubMed ID: 10580616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria.
    Lee YJ; Shin SJ; Tsai JH
    Diabetes Care; 1994 Apr; 17(4):263-6. PubMed ID: 8026280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does microalbuminuria predict diabetic nephropathy?
    Tabaei BP; Al-Kassab AS; Ilag LL; Zawacki CM; Herman WH
    Diabetes Care; 2001 Sep; 24(9):1560-6. PubMed ID: 11522699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of microalbuminuria in diabetes: a study from north India.
    Gupta DK; Verma LK; Khosla PK; Dash SC
    Diabetes Res Clin Pract; 1991 May; 12(2):125-8. PubMed ID: 1879303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Groop L; Ekstrand A; Forsblom C; Widén E; Groop PH; Teppo AM; Eriksson J
    Diabetologia; 1993 Jul; 36(7):642-7. PubMed ID: 8359582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    Ansquer JC; Foucher C; Rattier S; Taskinen MR; Steiner G;
    Am J Kidney Dis; 2005 Mar; 45(3):485-93. PubMed ID: 15754270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.